Anna Bradley-Smith  |  July 29, 2021

Category: Legal News

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

CBD labels - CBD- CBD Recall
(Photo Credit: Food Safety Authority of Ireland (FSAI))

CBD Recall Overview:

  • Who: CBD products sold under the brands CannabiGold, Canapol, The Healing Stone, Phyto+, and The Herb Stone have been recalled.
  • Why: The Food Safety Authority of Ireland found the products to contain “unsafe” levels of THC, the active ingredient in marijuana.
  • Where: The recalls apply to products sold in the Republic of Ireland.

A range of CBD products, including oils and food supplements, have been recalled in Ireland after they were found to contain “unsafe” levels of delta9tetrahydrocannabinol, also known as THC.

THC is the active ingredient in cannabis which gets users high. It is psychoactive and considered a narcotic. CBD, however, is not psychoactive, though research into its potential benefits and side effects is still ongoing.

The Food Safety Authority of Ireland (FSAI) issued the recall notice for products sold by brand names CannabiGold, Canapol, The Healing Stone, Phyto+, and The Herb Stone. 

A spokesperson for the FSAI told Thejournal.ie that distributors had been requested to withdraw the products from the market and retailers were requested to remove the products from sale.

“Food businesses that have sold the implicated batches of the implicated CBD products to consumers must display a point-of-sale notice in store and on websites if sold online, to inform consumers that the implicated batches of these CBD products are being recalled and the reason why.”

In Ireland, THC is controlled under the Misuse of Drugs Acts 1977.

In the United States, injectable CBD manufacturer Biota Biosciences agreed to voluntarily recall three of its products in June 2020 following a warning letter from the U.S. Food and Drug Administration (FDA).

The FDA warned the company that advertising the products as a treatment for opioid addiction made them subject to FDA rules governing the marketing of drugs. As a result, the FDA says the products are in violation of FDA regulations since they have not received FDA approval.

Do you use products containing CBD? Tell us the effects the products have on you in the comments section!


Don’t Miss Out!

Check out our list of Class Action Lawsuits and Class Action Settlements you may qualify to join!


Read About More Class Action Lawsuits & Class Action Settlements:

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

  • This field is for validation purposes and should be left unchanged.

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.